Hop, skip, and jump: do we need phase II cardiovascular clinical trials?
Publication
, Journal Article
O'Connor, CM
Published in: JACC Heart Fail
March 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
March 2015
Volume
3
Issue
3
Start / End Page
273 / 274
Location
United States
Related Subject Headings
- Humans
- Disease Management
- Congresses as Topic
- Clinical Trials, Phase II as Topic
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M. (2015). Hop, skip, and jump: do we need phase II cardiovascular clinical trials? JACC Heart Fail, 3(3), 273–274. https://doi.org/10.1016/j.jchf.2014.12.003
O’Connor, Christopher M. “Hop, skip, and jump: do we need phase II cardiovascular clinical trials?” JACC Heart Fail 3, no. 3 (March 2015): 273–74. https://doi.org/10.1016/j.jchf.2014.12.003.
O’Connor CM. Hop, skip, and jump: do we need phase II cardiovascular clinical trials? JACC Heart Fail. 2015 Mar;3(3):273–4.
O’Connor, Christopher M. “Hop, skip, and jump: do we need phase II cardiovascular clinical trials?” JACC Heart Fail, vol. 3, no. 3, Mar. 2015, pp. 273–74. Pubmed, doi:10.1016/j.jchf.2014.12.003.
O’Connor CM. Hop, skip, and jump: do we need phase II cardiovascular clinical trials? JACC Heart Fail. 2015 Mar;3(3):273–274.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
March 2015
Volume
3
Issue
3
Start / End Page
273 / 274
Location
United States
Related Subject Headings
- Humans
- Disease Management
- Congresses as Topic
- Clinical Trials, Phase II as Topic
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology